Header Logo

Debra L Richardson

TitleProf,Asoc
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentObstetrics and Gynecology
AddressSOCC 5050
800 NE 10th St
Oklahoma City OK 73104
Phone405/271-8707 ext 31839
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Richardson DL. The emerging use of antibody-drug conjugates in ovarian cancer. Clin Adv Hematol Oncol. 2023 05; 21(5):244-246. PMID: 37145494.
      Citations:    Fields:    Translation:Humans
    2. Richardson DL, Eskander RN, O'Malley DM. Advances in Ovarian Cancer Care and Unmet Treatment Needs for Patients With Platinum Resistance: A Narrative Review. JAMA Oncol. 2023 Apr 20. PMID: 37079311.
      Citations:    Fields:    
    3. Richardson DL. Ocular toxicity and mitigation strategies for antibody drug conjugates in gynecologic oncology. Gynecol Oncol Rep. 2023 Apr; 46:101148. PMID: 37033209; PMCID: PMC10073635.
      Citations:    
    4. Tymon-Rosario J, Gorman M, Richardson DL, Washington C, Santin AD. Advances in antibody-drug conjugates for gynecologic malignancies. Curr Opin Obstet Gynecol. 2023 02 01; 35(1):6-14. PMID: 36484278.
      Citations: 1     Fields:    Translation:Humans
    5. Zhou X, Richardson DL, Dowlati A, Goel S, Sahebjam S, Strauss J, Chawla S, Wang D, Mould DR, Samnotra V, Faller DV, Venkatakrishnan K, Gupta N. Effect of Pevonedistat, an Investigational NEDD8-Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid Tumors. Clin Pharmacol Drug Dev. 2023 03; 12(3):257-266. PMID: 36382849.
      Citations:    Fields:    Translation:Humans
    6. Banerjee S, Drapkin R, Richardson DL, Birrer M. Targeting NaPi2b in ovarian cancer. Cancer Treat Rev. 2022 Nov 14; 112:102489. PMID: 36446254.
      Citations:    Fields:    
    7. Krause D, Richardson DL. Is there a role for secondary debulking in ovarian cancer? A review of the current literature. Curr Opin Obstet Gynecol. 2023 02 01; 35(1):1-5. PMID: 36239548.
      Citations:    Fields:    Translation:Humans
    8. Hardesty MM, Krivak TC, Wright GS, Hamilton E, Fleming EL, Belotte J, Keeton EK, Wang P, Gupta D, Clements A, Gray HJ, Konecny GE, Moore RG, Richardson DL. OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab. Gynecol Oncol. 2022 08; 166(2):219-229. PMID: 35690498.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    9. Jackson CG, Moore KN, Cantrell L, Erickson BK, Duska LR, Richardson DL, Landrum LM, Holman LL, Walker JL, Mannel RS, Moxley KM, Queimado L, Cohoon A, Ding K, Dockery LE. A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium. Gynecol Oncol. 2022 07; 166(1):44-49. PMID: 35491267.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    10. Richardson DL. Should we or should we not? Secondary debulking in ovarian cancer. Lancet Oncol. 2021 04; 22(4):412-413. PMID: 33705694.
      Citations: 1     Fields:    Translation:Humans
    11. Gillen JM, Grimes SC, Essel KG, Duininck GE, Zhao D, Thompson JS, Richardson DL. Association of financial assistance programs and time to completion of therapy in women receiving chemoradiation for cervical cancer. Gynecol Oncol Rep. 2020 Nov; 34:100660. PMID: 33251312.
      Citations:    
    12. Tewari KS, Sill MW, Monk BJ, Penson RT, Moore DH, Lankes HA, Ramondetta LM, Landrum LM, Randall LM, Oaknin A, Leitao MM, Eisenhauer EL, DiSilvestro P, Van Le L, Pearl ML, Burke JJ, Salani R, Richardson DL, Michael HE, Kindelberger DW, Birrer MJ. Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062). Mol Cancer Ther. 2020 11; 19(11):2363-2370. PMID: 32847980.
      Citations: 7     Fields:    Translation:HumansCellsCTClinical Trials
    13. Son J, Chambers LM, Carr C, Michener CM, Yao M, Beavis A, Yen TT, Stone RL, Wethington SL, Fader AN, Burkett WC, Richardson DL, Staley AS, Ahn S, Gehrig PA, Torres D, Dowdy SC, Sullivan MW, Modesitt SC, Watson C, Veade A, Ehrisman J, Havrilesky L, Secord AA, Loreen A, Griffin K, Jackson A, Viswanathan A, Ricci S. Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion. Int J Gynecol Cancer. 2020 11; 30(11):1738-1747. PMID: 32771986.
      Citations: 1     Fields:    Translation:Humans
    14. Beavis AL, Yen TT, Stone RL, Wethington SL, Carr C, Son J, Chambers L, Michener CM, Ricci S, Burkett WC, Richardson DL, Staley AS, Ahn S, Gehrig PA, Torres D, Dowdy SC, Sullivan MW, Modesitt SC, Watson C, Veade A, Ehrisman J, Havrilesky L, Secord AA, Loreen A, Griffin K, Jackson A, Viswanathan AN, Jager LR, Fader AN. Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy? Gynecol Oncol. 2020 03; 156(3):568-574. PMID: 31948730.
      Citations: 6     Fields:    Translation:Humans
    15. Washington CR, Richardson DL, Moore KN. Olaparib in the treatment of ovarian cancer. Future Oncol. 2019 Oct; 15(30):3435-3449. PMID: 31478762.
      Citations: 6     Fields:    Translation:Humans
    16. Richardson DL. New and Novel Therapies for Gynecologic Cancers. Semin Oncol Nurs. 2019 Apr; 35(2):217-219. PMID: 30876683.
      Citations: 7     Fields:    Translation:Humans
    17. Gillen J, Richardson D, Moore K. Angiopoietin-1 and Angiopoietin-2 Inhibitors: Clinical Development. Curr Oncol Rep. 2019 02 26; 21(3):22. PMID: 30806847.
      Citations: 12     Fields:    Translation:HumansAnimals
    18. Manders DB, Sims TT, Bailey A, Hwang L, Richardson DL, Miller DS, Kehoe SM, Albuquerque KV, Lea JS. The Significance of Para-Aortic Nodal Size and the Role of Adjuvant Systemic Chemotherapy in Cervical Cancer: An Institutional Experience. Am J Clin Oncol. 2018 12; 41(12):1225-1230. PMID: 29782361.
      Citations: 7     Fields:    Translation:Humans
    19. Manders DB, Sims TT, Albuquerque KV, Carlson MJ, Richardson DL, Kehoe SM, Miller DS, Lea JS. Emphasis on Systemic Therapy in Women With Pelvic Bone Metastasis at Time of Diagnosis of Cervical Cancer. Am J Clin Oncol. 2018 Nov; 41(11):1137-1141. PMID: 29521650.
      Citations: 3     Fields:    
    20. Palavalli Parsons LH, Roane B, Manders DB, Richardson DL, Kehoe SM, Carlson M, Miller DS, Lea JS. Hypoalbuminemia is a Predictive Factor for Fistula Formation in Recurrent Cervical Cancer. Am J Clin Oncol. 2018 10; 41(10):933-937. PMID: 28817390.
      Citations: 4     Fields:    Translation:Humans
    21. Richardson DL, Seward SM, Moore KN. Antibody Drug Conjugates in the Treatment of Epithelial Ovarian Cancer. Hematol Oncol Clin North Am. 2018 12; 32(6):1057-1071. PMID: 30390760.
      Citations: 3     Fields:    Translation:Humans
    22. Richardson DL, Coleman RL, Sill MW. Paclitaxel and Pazopanib in Ovarian Cancer-Reply. JAMA Oncol. 2018 09 01; 4(9):1299. PMID: 29978183.
      Citations: 2     Fields:    Translation:Humans
    23. Manders DB, Kehoe SM, Miller DS, Lea JS, Richardson DL. Third-line Salvage Chemotherapy for Recurrent Carcinoma of the Cervix is Associated With Minimal Response Rate and High Toxicity. Am J Clin Oncol. 2018 08; 41(8):797-801. PMID: 28225444.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    24. Manders DB, Mor├│n A, McIntire D, Miller DS, Richardson DL, Kehoe SM, Albuquerque KV, Lea JS. Locally Advanced Cervical Cancer: Outcomes With Variable Adherence to Treatment. Am J Clin Oncol. 2018 05; 41(5):447-451. PMID: 27258678.
      Citations: 4     Fields:    Translation:Humans
    25. Parsons LHP, Pedersen R, Richardson DL, Kho KA. The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications. Eur J Obstet Gynecol Reprod Biol. 2018 Apr; 223:108-112. PMID: 29518640.
      Citations: 4     Fields:    Translation:Humans
    26. Richardson DL, Sill MW, Coleman RL, Sood AK, Pearl ML, Kehoe SM, Carney ME, Hanjani P, Van Le L, Zhou XC, Alvarez Secord A, Gray HJ, Landrum LM, Lankes HA, Hu W, Aghajanian C. Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial. JAMA Oncol. 2018 Feb 01; 4(2):196-202. PMID: 29242937.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    27. Cohn DE, Sill MW, Walker JL, O'Malley D, Nagel CI, Rutledge TL, Bradley W, Richardson DL, Moxley KM, Aghajanian C. Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 09; 146(3):477-483. PMID: 28756871.
      Citations: 28     Fields:    Translation:HumansCellsCTClinical Trials
    28. Conrad LB, Conrad SA, Miller DS, Richardson DL, Kehoe S, Lea JS. Factors influencing primary treatment of midline vulvar cancers. Gynecol Oncol. 2016 07; 142(1):133-138. PMID: 27132089.
      Citations:    Fields:    Translation:Humans
    29. Kho KA, Lin K, Hechanova M, Richardson DL. Risk of Occult Uterine Sarcoma in Women Undergoing Hysterectomy for Benign Indications. Obstet Gynecol. 2016 Mar; 127(3):468-473. PMID: 26855091.
      Citations: 12     Fields:    Translation:Humans
    30. Powell CB, Richardson DL, Chen LM. In response to Peshkin et al. "Genetic counseling and testing for hereditary cancer risk in young adult women: Facilitating autonomy and informed decision making is key". Gynecol Oncol Rep. 2015 Nov; 14:46. PMID: 26793775.
      Citations:    
    31. Lin KY, Miller DS, Bailey AA, Andrews SJ, Kehoe SM, Richardson DL, Lea JS. Ovarian involvement in endometrioid adenocarcinoma of uterus. Gynecol Oncol. 2015 Sep; 138(3):532-5. PMID: 26186908.
      Citations: 10     Fields:    Translation:Humans
    32. Davidson BA, Nagel CI, Richardson DL, Kehoe SM, Miller DS, Lea JS. Outcomes of Treatment of Gestational Trophoblastic Neoplasia in a Primarily Indigent Urban Population. J Reprod Med. 2015 May-Jun; 60(5-6):243-8. PMID: 26126310.
      Citations: 1     Fields:    Translation:Humans
    33. Lancaster JM, Powell CB, Chen LM, Richardson DL. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol. 2015 Jan; 136(1):3-7. PMID: 25238946.
      Citations: 98     Fields:    Translation:Humans
    34. Nagel CI, Thomas SK, Richardson DL, Kehoe SM, Miller DS, Lea JS. Adnexal masses requiring surgical intervention in women with advanced cervical cancer. Gynecol Oncol. 2014 Sep; 134(3):552-5. PMID: 25014542.
      Citations: 1     Fields:    Translation:Humans
    35. Manders DB, Paulsen A, Richardson DL, Kehoe SM, Miller DS, Lea JS. Factors associated with clinical trial screening failures in gynecologic oncology. Gynecol Oncol. 2014 Sep; 134(3):450-4. PMID: 24992676.
      Citations: 4     Fields:    Translation:Humans
    36. Lin KY, Bryant S, Miller DS, Kehoe SM, Richardson DL, Lea JS. Malignant ovarian germ cell tumor - role of surgical staging and gonadal dysgenesis. Gynecol Oncol. 2014 Jul; 134(1):84-9. PMID: 24836278.
      Citations: 12     Fields:    Translation:Humans
    37. Backes FJ, Richardson DL, McCann GA, Smith B, Salani R, Eisenhauer EL, Fowler JM, Copeland LJ, Cohn DE, O'Malley DM. Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer? Int J Gynecol Cancer. 2013 Jun; 23(5):833-8. PMID: 23640292.
      Citations: 5     Fields:    Translation:Humans
    38. Seamon LG, Richardson DL, Copeland LJ. Evolution of the Gynecologic Oncology Group protocols in the treatment of epithelial ovarian cancer. Clin Obstet Gynecol. 2012 Mar; 55(1):131-55. PMID: 22343234.
      Citations: 2     Fields:    Translation:Humans
    39. Boren TP, Carrick K, Kehoe SM, Lea J, Miller DS, Richardson DL. Correlation of cone biopsy with findings at radical hysterectomy and use of adjuvant radiation therapy. Gynecol Oncol. 2012 Mar; 124(3):508-11. PMID: 22108254.
      Citations: 1     Fields:    Translation:Humans
    40. O'Malley DM, Richardson DL, Rheaume PS, Salani R, Eisenhauer EL, McCann GA, Fowler JM, Copeland LJ, Cohn DE, Backes FJ. Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer. Gynecol Oncol. 2011 May 01; 121(2):269-72. PMID: 21315428.
      Citations: 21     Fields:    Translation:Humans
    41. Bakkum-Gamez JN, Richardson DL, Seamon LG, Aletti GD, Powless CA, Keeney GL, O'Malley DM, Cliby WA. Is there a high-risk subgroup of stage I epithelial ovarian cancer that is most likely to benefit from 6 versus 3 cycles of adjuvant chemotherapy? Int J Gynecol Cancer. 2010 Oct; 20(7):1125-31. PMID: 21495213.
      Citations:    Fields:    Translation:Humans
    42. Seamon LG, Cohn DE, Richardson DL, Hurt JD, Nickerson EC, Fowler JM. Robotic pelvic and aortic lymphadenectomy for endometrial cancer: the console surgeon's perspectives on surgical technique and directing the assistant. J Minim Invasive Gynecol. 2010 Mar-Apr; 17(2):180-5. PMID: 20226405.
      Citations: 2     Fields:    Translation:Humans
    43. Seamon LG, Carlson MJ, Richardson DL, Cohn DE, Fowler JM, Copeland LJ, O'Malley DM. Outpatient platinum-taxane intraperitoneal chemotherapy regimen for ovarian cancer. Int J Gynecol Cancer. 2009 Oct; 19(7):1195-8. PMID: 19823054.
      Citations: 1     Fields:    Translation:Humans
    44. Seward SM, Richardson DL, Leon ME, Zhao W, Cohn DE, Hitchcock CL. Metastatic squamous cell carcinoma of the vulva to the lung confirmed with allelotyping. Int J Gynecol Pathol. 2009 Sep; 28(5):497-501. PMID: 19696623.
      Citations: 3     Fields:    Translation:Humans
    45. Richardson DL, Seamon LG, Resnick KE, Martin D, Fowler JM. Isolated groin recurrence of vulvar cancer salvaged with multimodality therapy. Gynecol Oncol. 2009 Nov; 115(2):306-7. PMID: 19576621.
      Citations: 2     Fields:    Translation:Humans
    46. Seamon LG, Fowler JM, Richardson DL, Carlson MJ, Valmadre S, Phillips GS, Cohn DE. A detailed analysis of the learning curve: robotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer. Gynecol Oncol. 2009 Aug; 114(2):162-7. PMID: 19428096.
      Citations: 32     Fields:    Translation:Humans
    47. Seamon LG, Holt CN, Suarez A, Richardson DL, Carlson MJ, O'Malley DM. Paratubal borderline serous tumors. Gynecol Oncol. 2009 Apr; 113(1):83-5. PMID: 19189870.
      Citations: 6     Fields:    Translation:Humans
    48. Bakkum-Gamez JN, Richardson DL, Seamon LG, Aletti GD, Powless CA, Keeney GL, O'Malley DM, Cliby WA. Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer. Obstet Gynecol. 2009 Jan; 113(1):11-17. PMID: 19104354.
      Citations: 19     Fields:    Translation:Humans
    49. Seamon LG, Cohn DE, Richardson DL, Valmadre S, Carlson MJ, Phillips GS, Fowler JM. Robotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer. Obstet Gynecol. 2008 Dec; 112(6):1207-1213. PMID: 19037027.
      Citations: 27     Fields:    Translation:Humans
    50. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol. 2009 Jan; 112(1):55-9. PMID: 18954897.
      Citations: 264     Fields:    Translation:Humans
    51. Richardson DL, Backes FJ, Seamon LG, Zanagnolo V, O'Malley DM, Cohn DE, Fowler JM, Copeland LJ. Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer. Gynecol Oncol. 2008 Dec; 111(3):461-6. PMID: 18829088.
      Citations: 19     Fields:    Translation:Humans
    52. Richardson DL, Seamon LG, Carlson MJ, O'Malley DM, Fowler JM, Copeland LJ, Cohn DE. CA125 decline in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy. Gynecol Oncol. 2008 Nov; 111(2):233-6. PMID: 18768214.
      Citations: 6     Fields:    Translation:Humans
    53. Seamon LG, Cohn DE, Valmadre S, Richardson DL, Jayjohn LA, Jenson C, Lee K, Travis J, Nickerson E, Fowler JM. Robotic hysterectomy and lymphadenectomy for endometrial cancer: technical aspects and details of success-the Ohio State University method. J Robot Surg. 2008 Jul; 2(2):71-6. PMID: 27637503.
      Citations:    Fields:    
    54. Seamon LG, Richardson DL, Pierce M, O'Malley DM, Griffin S, Cohn DE. Local correction of extreme stomal prolapse following transverse loop colostomy. Gynecol Oncol. 2008 Dec; 111(3):549-51. PMID: 18304621.
      Citations: 5     Fields:    Translation:Humans
    55. Richardson DL, Seamon LG, Gong MC, Chapman DM, Cohn DE. Panniculectomy concurrent with anterior pelvic exenteration for recurrent cervical cancer. Gynecol Oncol. 2008 Feb; 108(2):449-51. PMID: 18042491.
      Citations:    Fields:    Translation:Humans
    56. Richardson DL, Mariani A, Cliby WA. Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer. Gynecol Oncol. 2006 Nov; 103(2):667-72. PMID: 16797684.
      Citations: 28     Fields:    Translation:Humans
    Richardson's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (180)
    Explore
    _
    Co-Authors (10)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _